Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
about
Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancerOverexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progressionA Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung CancerMUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patientsSerum amyloid A is elevated in the serum of lung cancer patients with poor prognosisQuantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured.Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer.Robust ultrasensitive tunneling-FET biosensor for point-of-care diagnostics.Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature.Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC PatientsProteomic approaches in lung cancer biomarker development.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort.Tumour-associated antigens and their anti-cancer applications.High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas.Comparative gene expression profiling analysis of lymphoblastoid cells reveals neuron-specific enolase gene (ENO2) as a susceptibility gene of heroin dependence.Neuron-specific enolase and blood sugar level in ischemic stroke patients.Declines in serum CYFRA21-1 and carcinoembryonic antigen as predictors of chemotherapy response and survival in patients with advanced non-small cell lung cancerIntegrating genomics and proteomics-oriented biomarkers to comprehend lung cancer.How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology.Understanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives.The Haptoglobin β chain as a supportive biomarker for human lung cancers.
P2860
Q24600990-7F31673E-1B50-4DAC-8543-F90656991150Q28483701-E5F10137-2382-40FF-9FF0-1DEA67A2D39AQ28547421-195DA750-F3FF-416E-B2F3-75B223AD0C3DQ33574955-56C3E009-B238-4529-BF76-84A22CDA5819Q33587249-21F948BC-2907-462C-A71D-BF8EFDFE9D19Q35078470-665F6A54-D7D4-4F3B-A729-44691E5CE299Q35906657-B9884D37-3FA8-4652-A3D7-0DADC09A1ABAQ36545001-D683DAA8-4DE5-44F5-B45B-1F326DD5FF2AQ36638436-A488EF4F-C849-4636-B6C8-243590B1BA7BQ36980801-C6781977-324C-4903-BA2B-2118630639E8Q37007121-2254AF7A-AAF8-4786-99F6-04D029B46AE9Q37390661-56F0DC7A-D062-4A2C-9FAB-D6285D529E7CQ38066244-01C25480-75E0-45B0-B7AB-C6B777903F8DQ38409413-68D4F004-DDB3-4878-82BE-9D6E2AE41CACQ38725552-379250F8-66EB-41C1-9AD5-91782DA5D5EAQ39098144-478A898B-D6BC-428F-8A86-0343890AAE67Q39458773-C347CD86-86D9-4B1B-98FC-B9550D597E96Q40828787-4C38765C-A823-466F-A2A9-364A5988E9F5Q42013318-27A43190-7F92-45F4-8161-D256E01FE303Q46190356-F9D9977D-7D83-4E13-A3D3-7F718CAD2F38Q52679143-F7E92278-63D0-4929-B0F8-0074110FDF29Q52679172-7A85C1C0-80DC-4311-A2C5-1847CE6C819DQ53441687-A2C59679-A63A-47ED-9EBE-2028119A97F8
P2860
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
@en
type
label
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
@en
prefLabel
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
@en
P1476
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
@en
P2093
William Chi-Shing Cho
P304
P356
10.1016/J.BIOPHA.2007.08.005
P577
2007-09-14T00:00:00Z